Stock data
ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (ACAD) reported revenue of US$1.07B and net income of US$391.00M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.07B | — | US$104.81M | US$391.00M | — |
| 2024 | US$957.80M | — | US$230.79M | US$226.45M | — |
| 2023 | US$726.44M | US$684.80M | -US$73.38M | -US$61.29M | — |
| 2022 | US$517.24M | US$507.07M | -US$223.60M | -US$215.97M | — |
| 2021 | US$484.14M | US$473.30M | -US$170.44M | -US$167.87M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$307.96M | US$31.50M | — |
| 2026-03-31 | US$268.06M | US$3.64M | — |
| 2025-12-31 | US$283.99M | US$273.57M | — |
| 2025-09-30 | US$278.63M | US$71.78M | — |
| 2025-06-30 | US$264.57M | US$26.67M | — |
| 2025-03-31 | US$244.32M | US$18.99M | — |
| 2024-12-31 | US$259.60M | US$143.74M | — |
| 2024-09-30 | US$250.40M | US$32.77M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.